Adequate serum levels of IGFBP2 inhibit differentiation of preadipocytes, and further hyperplasia and hypertrophy of visceral adipose tissue in both dependent and independent actions, which results in preventing obesity state (Figure 3). This evidence concerns the gene IGFBP2 and obesity disorder.